vs
Side-by-side financial comparison of Protalix BioTherapeutics, Inc. (PLX) and PIONEER POWER SOLUTIONS, INC. (PPSI). Click either name above to swap in a different company.
Protalix BioTherapeutics, Inc. is the larger business by last-quarter revenue ($9.1M vs $5.6M, roughly 1.6× PIONEER POWER SOLUTIONS, INC.). PIONEER POWER SOLUTIONS, INC. runs the higher net margin — -24.7% vs -60.3%, a 35.6% gap on every dollar of revenue. On growth, PIONEER POWER SOLUTIONS, INC. posted the faster year-over-year revenue change (-42.3% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-2.2M). Over the past eight quarters, PIONEER POWER SOLUTIONS, INC.'s revenue compounded faster (30.3% CAGR vs -6.7%).
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
Caterpillar Energy Solutions GmbH, is a mechanical engineering company based in Mannheim, Baden-Württemberg, Germany. It was known as MWM GmbH Motoren-Werke Mannheim (MWM) until November 2013. In 2009 the company was the third-largest producer by revenue of gas and diesel engines.
PLX vs PPSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $5.6M |
| Net Profit | $-5.5M | $-1.4M |
| Gross Margin | 49.4% | 23.5% |
| Operating Margin | -51.1% | -19.4% |
| Net Margin | -60.3% | -24.7% |
| Revenue YoY | -49.9% | -42.3% |
| Net Profit YoY | -184.8% | -103.8% |
| EPS (diluted) | $-0.06 | $-0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | $5.6M | ||
| Q3 25 | $17.9M | $6.9M | ||
| Q2 25 | $15.7M | $8.4M | ||
| Q1 25 | $10.1M | $6.7M | ||
| Q4 24 | $18.2M | $9.8M | ||
| Q3 24 | $18.0M | $6.4M | ||
| Q2 24 | $13.5M | $3.4M | ||
| Q1 24 | — | $3.3M |
| Q4 25 | $-5.5M | $-1.4M | ||
| Q3 25 | $2.4M | $-2.4M | ||
| Q2 25 | $164.0K | $-1.3M | ||
| Q1 25 | $-3.6M | $-929.0K | ||
| Q4 24 | $6.5M | $36.3M | ||
| Q3 24 | $3.2M | $-1.1M | ||
| Q2 24 | $-2.2M | $-2.3M | ||
| Q1 24 | — | $-1.0M |
| Q4 25 | 49.4% | 23.5% | ||
| Q3 25 | 53.4% | 9.3% | ||
| Q2 25 | 62.5% | 15.7% | ||
| Q1 25 | 19.1% | 2.2% | ||
| Q4 24 | 78.7% | 28.9% | ||
| Q3 24 | 53.4% | 23.7% | ||
| Q2 24 | 29.8% | 18.9% | ||
| Q1 24 | — | 16.1% |
| Q4 25 | -51.1% | -19.4% | ||
| Q3 25 | 11.9% | -21.0% | ||
| Q2 25 | 7.5% | -20.4% | ||
| Q1 25 | -41.0% | -34.8% | ||
| Q4 24 | 39.6% | -11.0% | ||
| Q3 24 | 22.2% | -11.1% | ||
| Q2 24 | -18.0% | -51.1% | ||
| Q1 24 | — | -52.1% |
| Q4 25 | -60.3% | -24.7% | ||
| Q3 25 | 13.2% | -34.1% | ||
| Q2 25 | 1.0% | -15.9% | ||
| Q1 25 | -35.8% | -13.8% | ||
| Q4 24 | 35.6% | 372.1% | ||
| Q3 24 | 18.0% | -17.5% | ||
| Q2 24 | -16.4% | -67.2% | ||
| Q1 24 | — | -31.2% |
| Q4 25 | $-0.06 | $-0.12 | ||
| Q3 25 | $0.03 | $-0.21 | ||
| Q2 25 | $0.00 | $-0.12 | ||
| Q1 25 | $-0.05 | $-0.09 | ||
| Q4 24 | $0.10 | $3.31 | ||
| Q3 24 | $0.03 | $-0.10 | ||
| Q2 24 | $-0.03 | $-0.21 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.2M | $29.3M |
| Total Assets | $82.3M | $35.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.6M | — | ||
| Q2 25 | $17.9M | $18.0M | ||
| Q1 25 | $19.5M | $25.8M | ||
| Q4 24 | $19.8M | $41.6M | ||
| Q3 24 | $27.4M | $3.1M | ||
| Q2 24 | $23.4M | $6.5M | ||
| Q1 24 | — | $6.2M |
| Q4 25 | $48.2M | $29.3M | ||
| Q3 25 | $52.9M | $30.7M | ||
| Q2 25 | $49.9M | $33.0M | ||
| Q1 25 | $45.2M | $34.5M | ||
| Q4 24 | $43.2M | $35.4M | ||
| Q3 24 | $32.4M | $14.7M | ||
| Q2 24 | $28.6M | $15.8M | ||
| Q1 24 | — | $18.1M |
| Q4 25 | $82.3M | $35.5M | ||
| Q3 25 | $82.3M | $37.6M | ||
| Q2 25 | $78.5M | $39.1M | ||
| Q1 25 | $73.9M | $47.5M | ||
| Q4 24 | $73.4M | $66.0M | ||
| Q3 24 | $61.6M | $40.1M | ||
| Q2 24 | $91.5M | $38.0M | ||
| Q1 24 | — | $39.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-1.0M |
| Free Cash FlowOCF − Capex | $1.6M | $-2.2M |
| FCF MarginFCF / Revenue | 17.8% | -38.8% |
| Capex IntensityCapex / Revenue | 4.4% | 20.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.6M | $-8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | $-1.0M | ||
| Q3 25 | $-3.7M | $-817.0K | ||
| Q2 25 | $-5.2M | $-5.5M | ||
| Q1 25 | $-5.1M | $1.5M | ||
| Q4 24 | $4.0M | $-2.1M | ||
| Q3 24 | $4.1M | $-2.7M | ||
| Q2 24 | $-3.6M | $571.0K | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | $1.6M | $-2.2M | ||
| Q3 25 | $-4.2M | $-1.6M | ||
| Q2 25 | $-5.7M | $-5.6M | ||
| Q1 25 | $-5.4M | $907.0K | ||
| Q4 24 | $3.6M | $-4.6M | ||
| Q3 24 | $4.0M | $-3.4M | ||
| Q2 24 | $-3.8M | $170.0K | ||
| Q1 24 | — | $-2.2M |
| Q4 25 | 17.8% | -38.8% | ||
| Q3 25 | -23.7% | -23.4% | ||
| Q2 25 | -36.2% | -67.0% | ||
| Q1 25 | -53.0% | 13.5% | ||
| Q4 24 | 19.6% | -46.9% | ||
| Q3 24 | 22.4% | -53.0% | ||
| Q2 24 | -28.1% | 5.0% | ||
| Q1 24 | — | -65.2% |
| Q4 25 | 4.4% | 20.3% | ||
| Q3 25 | 2.8% | 11.5% | ||
| Q2 25 | 2.8% | 1.7% | ||
| Q1 25 | 3.0% | 8.8% | ||
| Q4 24 | 2.3% | 25.4% | ||
| Q3 24 | 0.5% | 10.3% | ||
| Q2 24 | 1.3% | 11.8% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | -0.06× | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
PPSI
| Total Revenue | $4.0M | 70% |
| Other | $1.7M | 30% |
